A great way to ended the year 2023! The participation of Dr. Nathalie MAUBON and Dr. Meryl ROUDAUT to represent HCS Pharma at HACKOSAKA event in december 2023 in Japan was an excellent opportunity to once again promote the results of research with our extracellular matrix 3Dmodel, BIOMIMESYS.
We are honored to have been the only French biotech invited to this prestigious celebration of innovation and scientific novelty among scientist and designers.
HACKOSAKA has provided HCS Pharma with a unique platform to foster collaborations and partnerships with other companies and industry researchers. The international reach of the event allowed our biotechnology to showcase its capabilities to a diverse audience and explore potential global collaboration.
Supported by our partners Jetro and AS ONE we were able to exhibit our technology in the best conditions and promote advantages of using BIOMIMESYS for your drug discovery research. An event that will seduce more than one for the year 2024!
Find more information in our Press releases section –> Retour sur le temps fort ! HCS Pharma invité d’honneur au Japon pour participé au HACKOSAKA 2023